These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2885827)

  • 1. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
    Rapisarda V; Azzaro E; Fichera G
    Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
    Sebban C; Tesolin B; Guez D
    Presse Med; 1987 Jun; 16(23):1154-8. PubMed ID: 2885826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
    Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
    Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
    Depresseux JC; Franck G; Van Cauwenberge H
    Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
    Berthaux P; Laforestrie R
    Presse Med; 1983 Mar; 12(13):852-5. PubMed ID: 6220336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
    Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke and functional rehabilitation: the Chinese experience.
    Li SW
    Eur Neurol; 1998; 39 Suppl 1():26-30. PubMed ID: 9516072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of almitrine-raubasine. An overview.
    Allain H; Bentué-Ferrer D
    Eur Neurol; 1998; 39 Suppl 1():39-44. PubMed ID: 9516074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
    Memin Y
    Presse Med; 1983 Mar; 12(13):849-51. PubMed ID: 6220335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
    Poitrenaud J; Laurent B; Sebban C
    Eur Neurol; 1995; 35 Suppl 1():43-6. PubMed ID: 8529729
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of almitrine/raubasine on cerebral metabolism in the elderly].
    Allain H; Bentué-Ferrer D
    Presse Med; 2002 Mar; 31(12):562-4. PubMed ID: 11984975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.